The various aggregation states of β-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression

被引:109
作者
Tamagno, Elena
Bardini, Paola
Guglielmotto, Michela
Danni, Oliviero
Tabaton, Massimo
机构
[1] Univ Turin, Dept Expt Med & Oncol, Gen Pathol Sect, I-10125 Turin, Italy
[2] Univ Genoa, Dept Neurosci Ophthalmol & Genet, Genoa, Italy
关键词
Alzheimer disease; fibrillar A beta(1-42); prefibrillar A beta(1-42); oligomeric A beta(1-42); oxidative stress; BACE-1; free radicals;
D O I
10.1016/j.freeradbiomed.2006.01.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid cascade hypothesis suggests that the insoluble and fibrillar form of beta-amyloid (A beta) may play a primary pathogenic role in Alzheimer disease at the molecular level. However, neither the rate of dementia nor the extent of neuronal change seems to correlate with the levels of amyloidotic plaques (i.e., aggregated/fibrillar A beta). Recent evidence suggests, however, that neurotoxicity may be exerted also by rather small soluble aggregates of A beta, including oligomers. To characterize the mechanisms underlying toxicity mediated by the various aggregation states of A beta peptides is then a major goal of research. In this work we investigated the effects of fibrillar, prefibrillar, and oligomeric A beta(1-42) on the induction of oxidative stress, cell death, and BACE-1 expression in NT2 neuronal cells. We found that prefibrillar and oligomefic A beta(1-42) resulted in a more dramatic increase in the oxidative stress markers 4-hydroxynonenal and hydrogen peroxide compared to fibrillar A beta(1-42). Moreover, increased oxidative stress levels also resulted in a more rapid and significant induction of both apoptotic and necrotic neuronal cell death. Accordingly, fibrillar A beta(1-42), but not the soluble nonfibrillar forms, was the only condition able to up-regulate BACE-1 expression and activity. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:202 / 212
页数:11
相关论文
共 57 条
[1]   HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, JB ;
LESLEY, R ;
SCHUBERT, D .
CELL, 1994, 77 (06) :817-827
[2]   Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid β-peptide (1-42) into rat brain:: Implications for Alzheimer's disease [J].
Boyd-Kimball, D ;
Sultana, R ;
Poon, HF ;
Lynn, BC ;
Casamenti, F ;
Pepeu, G ;
Klein, JB ;
Butterfield, DA .
NEUROSCIENCE, 2005, 132 (02) :313-324
[3]   STAGING OF ALZHEIMER-RELATED CORTICAL DESTRUCTION [J].
BRAAK, H ;
BRAAK, E ;
BOHL, J .
EUROPEAN NEUROLOGY, 1993, 33 (06) :403-408
[4]  
Butterfield DA, 2004, BRAIN PATHOL, V14, P426
[5]   Toxicity of amyloid β peptide:: Tales of calcium, mitochondria, and oxidative stress [J].
Canevari, L ;
Abramov, AY ;
Duchen, MR .
NEUROCHEMICAL RESEARCH, 2004, 29 (03) :637-650
[6]   Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation [J].
Chui, DH ;
Tanahashi, H ;
Ozawa, K ;
Ikeda, S ;
Checler, F ;
Ueda, O ;
Suzuki, H ;
Araki, W ;
Inoue, H ;
Shirotani, K ;
Takahashi, K ;
Gallyas, F ;
Tabira, T .
NATURE MEDICINE, 1999, 5 (05) :560-564
[7]   Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc [J].
Cuajungco, MP ;
Goldstein, LE ;
Nunomura, A ;
Smith, MA ;
Lim, JT ;
Atwood, CS ;
Huang, XD ;
Farrag, YW ;
Perry, G ;
Bush, AI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (26) :19439-19442
[8]   Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability [J].
Dahlgren, KN ;
Manelli, AM ;
Stine, WB ;
Baker, LK ;
Krafft, GA ;
LaDu, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :32046-32053
[9]   In vitro model of neurotoxicity of Aβ 1-42 and neuroprotection by a pentapeptide:: irreversible events during the first hour [J].
Datki, Z ;
Papp, R ;
Zádori, D ;
Soós, K ;
Fülöp, L ;
Juhász, A ;
Laskay, G ;
Hetényi, C ;
Mihalik, E ;
Zarándi, M ;
Penke, B .
NEUROBIOLOGY OF DISEASE, 2004, 17 (03) :507-515
[10]   Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model [J].
Dodart, JC ;
Bales, KR ;
Gannon, KS ;
Greene, SJ ;
DeMattos, RB ;
Mathis, C ;
DeLong, CA ;
Wu, S ;
Wu, X ;
Holtzman, DM ;
Paul, SM .
NATURE NEUROSCIENCE, 2002, 5 (05) :452-457